Arrowhead Pharmaceuticals (ARWR) EBIT Margin (2010 - 2026)
Arrowhead Pharmaceuticals' EBIT Margin came in at -226.03% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 370.18 percentage points from -596.21% a year earlier but down 34.46 percentage points from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) EBIT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported EBIT Margin of -33.82%, down 14.98 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was 11.86%, up 16938.92 percentage points from FY2024.
- EBIT Margin carries a five-year change of +117.73 percentage points (FY2020 to FY2025).
- Going back by fiscal year, EBIT Margin was -16927.06% in FY2024 (-16841.91 pp), -85.16% in FY2023 (-11.77 pp), -73.39% in FY2022 (+34.38 pp) and -107.77% in FY2021 (-1.90 pp).
- The five-year range for quarterly EBIT Margin is -6456.48% (fiscal Q1 2025) to 70.24% (fiscal Q2 2025).
- Year-over-year, EBIT Margin increased in two of the last four quarters, with an average year-over-year change of +992.27 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in fiscal Q1 2026 (a gain of 6471.94 percentage points), and the weakest in fiscal Q1 2024 (a drop of 3777.89 percentage points).
- Business Quant data shows ARWR's EBIT Margin at -191.57% (Q2 2026), 15.46% (Q1 2026) and 17.20% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | -226.03% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -226.03% |
| Mar 31, 2026 | -191.57% |
| Dec 31, 2025 | 15.46% |
| Sep 30, 2025 | 17.20% |
| Jun 30, 2025 | -596.21% |
| Mar 31, 2025 | 70.24% |
| Dec 31, 2024 | -6,456.48% |
| Dec 31, 2023 | -3,845.25% |
| Sep 30, 2023 | -672.98% |
| Jun 30, 2023 | -648.99% |
| Mar 31, 2023 | 32.93% |
| Dec 31, 2022 | -67.36% |
| Sep 30, 2022 | -265.49% |
| Jun 30, 2022 | -224.94% |
| Mar 31, 2022 | 27.37% |
| Dec 31, 2021 | -230.77% |
| Sep 30, 2021 | -169.48% |
| Jun 30, 2021 | -69.44% |
| Mar 31, 2021 | -86.04% |
| Dec 31, 2020 | -112.91% |
Arrowhead Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();